21 CFR Part 111 · Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements

21 CFR 111.403

What are the requirements under this subpart L for written procedures?

21 CFR 111.403 is the regulation titled “What are the requirements under this subpart L for written procedures?” in 21 CFR Part 111, Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. Since 2021, 1 FDA warning letter has cited it.

Letters citing it
1 since 2021
Jan 1 to Oct 30, 2026
0 against 0 on the same dates in 2025
Most often cited with
21 CFR 101.12, in 1 letter
Closed out
0% of these letters have a published close-out
See the letter citing 21 CFR 111.403 →

Letters citing it, by year issued

It is a drug letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 12022
  3. 02023
  4. 02024
  5. 02025
  6. 02026

The regulation

Read the text of 21 CFR 111.403 (eCFR, as of Sep 1, 2026)

You must establish and follow written procedures for packaging and labeling operations.

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 111.403.

Latest letters citing it

The letter citing 21 CFR 111.403 that FDA posted most recently.

See the letter citing 21 CFR 111.403 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.